G Luetic
Overview
Explore the profile of G Luetic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
39
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luetic G, Menichini M
Mult Scler Relat Disord
. 2020 Feb;
41:102006.
PMID: 32087592
No abstract available.
2.
Luetic G
Int MS J
. 2008 Aug;
15(1):6-11.
PMID: 18713563
During the last few years, there has been an increasing desire to study and expand current knowledge about the different aspects of Multiple Sclerosis (MS) in Latin America (LATAM). This...
3.
Melcon M, Gold L, Carra A, Caceres F, Correale J, Cristiano E, et al.
Mult Scler
. 2008 Jun;
14(5):656-62.
PMID: 18566029
There are few studies reporting multiple sclerosis prevalence rates in the Buenos Aires region, Argentina (latitude 34 degrees S) (between 12-18.5/100 000 inhabitants), and no studies have been performed in...
4.
Carra A, Onaha P, Luetic G, Burgos M, Crespo E, Deri N, et al.
Eur J Neurol
. 2008 Mar;
15(4):386-93.
PMID: 18353125
Switching treatment may be beneficial in patients with relapsing-remitting multiple sclerosis (RRMS) who respond inadequately to first-line immunomodulatory therapy. The objective of this study was to evaluate clinical outcomes after...
5.
Carra A, Rivera-Olmos V, Arcega R, Gabbai A, Haussen S, Luetic G, et al.
Rev Neurol
. 2006 Apr;
42(7):399-407.
PMID: 16602056
Introduction: Considerable progress has been made in the treatment of patients with relapsing-remitting multiple sclerosis (MS) over the last decade. Exactly how these changes are reflected in daily practice, however,...
6.
Carra A, Onaha P, Sinay V, Alvarez F, Luetic G, Bettinelli R, et al.
Eur J Neurol
. 2003 Dec;
10(6):671-6.
PMID: 14641512
We performed an observational, retrospective analysis of outcome in a sequential cohort of patients with relapsing-remitting multiple sclerosis (RRMS) in Argentina. Patients treated for 16 months with interferon beta-1a (Avonex;...